BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26525783)

  • 21. An unlabelled probe-based real time PCR and modified semi-nested PCR as molecular tools for analysis of chloroquine resistant Plasmodium vivax isolates from Afghanistan.
    Mosawi SH; Dalimi A; Safi N; Fotouhi-Ardakani R; Ghaffarifar F; Sadraei J
    Malar J; 2020 Jul; 19(1):253. PubMed ID: 32664942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia.
    Chaorattanakawee S; Lon C; Chann S; Thay KH; Kong N; You Y; Sundrakes S; Thamnurak C; Chattrakarn S; Praditpol C; Yingyuen K; Wojnarski M; Huy R; Spring MD; Walsh DS; Patel JC; Lin J; Juliano JJ; Lanteri CA; Saunders DL
    Malar J; 2017 Sep; 16(1):392. PubMed ID: 28964258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of in vitro drug susceptibility testing of Plasmodium vivax.
    Russell B; Chalfein F; Prasetyorini B; Kenangalem E; Piera K; Suwanarusk R; Brockman A; Prayoga P; Sugiarto P; Cheng Q; Tjitra E; Anstey NM; Price RN
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1040-5. PubMed ID: 18180357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of Mutations Associated with Antifolate and Chloroquine Resistance among Imported
    Bansal D; Acharya A; Bharti PK; Abdelraheem MH; Elmalik A; Abosalah S; Khan FY; ElKhalifa M; Kaur H; Mohapatra PK; Sehgal R; Idris MA; Mahanta J; Singh N; Babiker HA; Sultan AA
    Am J Trop Med Hyg; 2017 Dec; 97(6):1797-1803. PubMed ID: 29016333
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessing the in vitro sensitivity with associated drug resistance polymorphisms in Plasmodium vivax clinical isolates from Delhi, India.
    Matlani M; Kumar A; Singh V
    Exp Parasitol; 2021 Jan; 220():108047. PubMed ID: 33221328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
    Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Noviyanti R; Kenangalem E; Poespoprodjo JR; Burgess SJ; Peyton DH; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5721-6. PubMed ID: 26149984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India.
    Shalini S; Chaudhuri S; Sutton PL; Mishra N; Srivastava N; David JK; Ravindran KJ; Carlton JM; Eapen A
    Malar J; 2014 Mar; 13():129. PubMed ID: 24685286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No Association between the Plasmodium vivax
    Rumaseb A; Moraes Barros RR; Sá JM; Juliano JJ; William T; Braima KA; Barber BE; Anstey NM; Price RN; Grigg MJ; Marfurt J; Auburn S
    Antimicrob Agents Chemother; 2023 Jul; 67(7):e0161022. PubMed ID: 37314336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular surveillance of chloroquine resistance in Plasmodium vivax isolates from malaria cases in Yunnan Province of China using pvcrt-o gene polymorphisms.
    Ding H; Dong Y; Deng Y; Xu Y; Liu Y; Wu J; Chen M; Zhang C; Liu L; Lin Y
    Malar J; 2023 Nov; 22(1):338. PubMed ID: 37940956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.
    Suwanarusk R; Russell B; Chavchich M; Chalfein F; Kenangalem E; Kosaisavee V; Prasetyorini B; Piera KA; Barends M; Brockman A; Lek-Uthai U; Anstey NM; Tjitra E; Nosten F; Cheng Q; Price RN
    PLoS One; 2007 Oct; 2(10):e1089. PubMed ID: 17971853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analytical method for assessing stage-specific drug activity in Plasmodium vivax malaria: implications for ex vivo drug susceptibility testing.
    Kerlin DH; Boyce K; Marfurt J; Simpson JA; Kenangalem E; Cheng Q; Price RN; Gatton ML
    PLoS Negl Trop Dis; 2012; 6(8):e1772. PubMed ID: 22880143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes.
    Wirjanata G; Handayuni I; Prayoga P; Leonardo L; Apriyanti D; Trianty L; Wandosa R; Gobay B; Kenangalem E; Poespoprodjo JR; Noviyanti R; Kyle DE; Cheng Q; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial.
    Grigg MJ; William T; Menon J; Barber BE; Wilkes CS; Rajahram GS; Edstein MD; Auburn S; Price RN; Yeo TW; Anstey NM
    Clin Infect Dis; 2016 Jun; 62(11):1403-1411. PubMed ID: 27107287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro sensitivity of Plasmodium falciparum to conventional and novel antimalarial drugs in Papua New Guinea.
    Wong RP; Lautu D; Tavul L; Hackett SL; Siba P; Karunajeewa HA; Ilett KF; Mueller I; Davis TM
    Trop Med Int Health; 2010 Mar; 15(3):342-9. PubMed ID: 20070627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Proportion of Genome-Wide Homology and Increased Pretreatment
    Rovira-Vallbona E; Van Hong N; Kattenberg JH; Huan RM; Binh NTH; Ngọc NTH; Guetens P; Hieu NL; Hien NTT; Sang VT; Long ND; Sauve E; Duong TT; Xa NX; Erhart A; Rosanas-Urgell A
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0009521. PubMed ID: 34031050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.
    Ranjitkar S; Schousboe ML; Thomsen TT; Adhikari M; Kapel CM; Bygbjerg IC; Alifrangis M
    Malar J; 2011 Apr; 10():75. PubMed ID: 21457533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of molecular markers associated with drug resistance of Plasmodium vivax isolates in Western Yunnan Province, China.
    Wang X; Ruan W; Zhou S; Feng X; Yan H; Huang F
    BMC Infect Dis; 2020 Apr; 20(1):307. PubMed ID: 32334523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in genes associated with drug resistance of Plasmodium vivax in India.
    Anantabotla VM; Antony HA; Parija SC; Rajkumari N; Kini JR; Manipura R; Nag VL; Gadepalli R; Chayani N; Patro S
    Parasitol Int; 2019 Jun; 70():92-97. PubMed ID: 30836136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms in chloroquine resistance-associated genes in Plasmodium vivax in Ethiopia.
    Golassa L; Erko B; Baliraine FN; Aseffa A; Swedberg G
    Malar J; 2015 Apr; 14():164. PubMed ID: 25889237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms of potential drug resistant molecular markers in Plasmodium vivax from China-Myanmar border during 2008‒2017.
    Wang Z; Wei C; Pan Y; Wang Z; Ji X; Chen Q; Zhang L; Wang Z; Wang H
    Infect Dis Poverty; 2022 Apr; 11(1):43. PubMed ID: 35462549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.